FDA establishment 3008581988, Pithampur, District Dhar, India. Part of Cipla's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, its recalls since 2016, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 1 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
| Feb 17, 2023 | Drugs · Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| May 17, 2019 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Apr 13, 2018 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Aug 7, 2015 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Mar 1, 2013 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Nov 2, 2012 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Recalled product | Class | Classified |
|---|---|---|
| Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd.…Drug · D-0197-2026 | Class II | Oct 31, 2025 |
| DIPHENHYDRAMINE HCL (ANTI-HISTAMINIC)Drugs · 61XCY18 | Jan 8, 2025 | |
| CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)Drugs · 61FCY54 | Jan 8, 2025 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections. FDA Data Dashboard, warning letters and enforcement reports